Authors: Labaune, JM Bleyzac, N Maire, P Jelliffe, RW Boutroy, MJ Aulagner, G Putet, G

Citation: Jm. Labaune et al., Once-a-day individualized amikacin dosing for suspected infection at birthbased on population pharmacokinetic models, BIOL NEONAT, 80(2), 2001, pp. 142-147

Authors: Hascoet, JM Hamon, I Boutroy, MJ

Citation: Jm. Hascoet et al., Risks and benefits of therapies for apnoea in premature infants, DRUG SAFETY, 23(5), 2000, pp. 363-379

Authors: Barbe, F Hansen, C Badonnel, Y Legagneur, H Vert, P Boutroy, MJ

Citation: F. Barbe et al., Severe side effects and drug plasma concentrations in preterm infants treated with doxapram, THER DRUG M, 21(5), 1999, pp. 547-552

Authors: Moftaquir-Handaj, A Jafari, S Boutroy, MJ

Citation: A. Moftaquir-handaj et al., Neonatal catecholamine content of adrenal and extra-adrenal chromaffin tissue after prenatal exposure to dexamethasone, PEDIAT RES, 45(1), 1999, pp. 60-65